𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Localization of growth hormone-release-inhibiting hormone (somatostatin) in the rat brain

✍ Scribed by Pelletier, Georges ;Leclerc, Rachel ;Dube, Donald ;Labrie, Fernand ;Puviani, Romano ;Arimura, Akira ;Schally, Andrew V.

Publisher
Wiley (John Wiley & Sons)
Year
1975
Tongue
English
Weight
288 KB
Volume
142
Category
Article
ISSN
0002-9106

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Utilizing an immunoperoxidase technique at the light microscope level, growth hormone‐release‐inhibiting hormone (somatostatin) was localized in the external zone of the median eminence, the subcommissural organ, the organum vasculosum of the lamina terminal is and the pineal gland. No positive reaction was detected in any other brain area.

πŸ“œ SIMILAR VOLUMES

Inhibition of the growth of caki-I human
Inhibition of the growth of caki-I human renal adenocarcinoma in Vivo by luteinizing hormone-releasing hormone antagonist cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II
✍ Andreas Jungwirth; Andrew V. Schally; Gabor Halmos; Kate Groot; Karoly Szepeshaz πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 224 KB πŸ‘ 2 views

## Background: Metastatic or recurrent renal cell carcinoma (rcc) is a therapeutic challenge because it is resistant to chemotherapy and external radiotherapy. no uniformly effective therapeutic agents are available for the management of patients with rcc. hormones and growth factors may play a rol

Targeted cytotoxic analog of luteinizing
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice
✍ KoppοΏ½n, Miklos; Nagy, Attila; Schally, Andrew V.; Plonowski, Artur; Halmos, GοΏ½bo πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 238 KB πŸ‘ 2 views

## Background: Receptors for luteinizing hormone-releasing hormone (lh-rh) found in prostate cancers might be used for targeting of chemotherapeutic agents. doxorubicin derivative 2-pyrrolinodoxorubicin (an-201) can be linked to carrier analog [d-lys6]lh-rh to form the targeted cytotoxic analog of

Luteinizing hormone-releasing hormone an
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
✍ Jungwirth, Andreas; Galvan, Georg; Pinski, Jacek; Halmos, Gabor; Szepeshazi, Kar πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 2 views

## Background: Hormones like bombesin (bn)/gastrin-releasing peptide (grp) and luteinizing hormone-releasing hormone (lh-rh) and growth factors such as epidermal growth factor (egf) might be involved in the relapse of prostate cancer under androgen ablation therapy. interference with receptors for